| 期刊論文| 1. | Sproule, B. A.、Naranjo, C. A.、Bremner, K. E.、Hassan, P. C.(1997)。Selective serotonin reuptake inhibitors and CNS drug interactions: A critical review of the evidence。Clin Pharmacokinet，33，454-471。   | | 2. | Plowchalk, D. R.、Rowland, Yeo K.(2012)。Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2。Eur J Clin Pharmacol，68，951-960。 | | 3. | Meltzer, H. Y.(2013)。Update on typical and atypical antipsychotic drugs。Annu Rev Med，64，393-406。 | | 4. | Lieberman, J. A.、Kane, J. M.、Johns, C. A.(1989)。Clozapine: guidelines for clinical management。J Clin Psychiatry，50，329-338。 | | 5. | Bondolfi, G.、Morel, F.、Crettol, S.、Rachid, F.、Baumann, P.、Eap, C. B.(2005)。Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients。Ther Drug Monit，27，539-543。 | | 6. | Taylor, D. M.、Douglas-Hall, P.、Olofinjana, B.、Whiskey, E.、Thomas, A.(2009)。Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection。The British Journal of Psychiatry，194，165-167。 | | 7. | Hinkes, R.、Quesada, T. V.、Currier, M. B.、Gonzalez-Bianco. M.(1996)。Aspiration pneumonia possibly secondary to clozapine-induced sialorrhea。J Clin Psychopharmacol，16，462-463。 | | 8. | Italiano, D.、Spina, E.、de Leon, J.(2014)。Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants。Expert Opin Drug Metab Toxicol，10，1457-1489。 | | 9. | Pearlman, C.(1994)。Clozapine, nocturnal sialorrhea, and Choking。J Clin Psychopharmacol，14，283。 | | 10. | Røge, R.、Møller, B. K.、Andersen, C. R.、Correll, C. U.、Nielsen, J.(2012)。Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?。Schizophr Res，140，204-213。 | | 11. | Pollmächer, T.、Fenzel, T.、Mullington, J.、Hinze-Selch, D.(1997)。The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels。Pharmacopsychiatry，30，118-121。 | | 12. | Pollmächer, T.、Hinze-Selch, D.、Mullington, J.(1996)。Effects of clozapine on plasma cytokine and soluble cytokine receptor levels。J Clin Psychopharmacol，16，403-409。 | | 13. | Maes, M.、Meltzer, H. Y.、Bosmans, E.(1994)。Immuneinflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine。Acta Psychiatr Scand，89，346-351。 | | 14. | Abdel-Razzak, Z.、Loyer, P.、Fautrel, A.、Gautier, J. C.、Corcos, L.、Turlin, B.(1993)。Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture。Mol Pharmacol，44，707-715。 | | 15. | Bleau, A. M.、Maurel, P.、Pichette, V.、Leblond, F.、du Souich, P.(2003)。Interleukin-1 beta, interleukin-6, tumour necrosis factor-alpha and interferongamma released by a viral infection and an aseptic inflammation reduce CYPlAl, 1A2 and 3A6 expression in rabbit hepatocytes。Eur J Pharmacol，473，197-206。 | | 16. | Bertilsson, L.、Carrillo, J. A.、Dahl, M. L.、Llerena, A.、Alm, C.、Bondesson, U.(1994)。Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test。Br J Clin Pharmacol，38，471-473。 | | 17. | Kuo, C. J.、Yang, S. Y.、Liao, Y. T.、Chen, W. J.、Lee, W. C.、Shau, W. Y.(2013)。Second-generation antipsychotic medications and risk of pneumonia in schizophrenia。Schizophr Bull，39，648-657。 | | 18. | de Leon, J.(2004)。Respiratory infections rather than antibiotics may increase clozapine levels: a critical review of the literature。J Clin Psychiatry，65，1144-1145。 | | 19. | Finley, P.、Warner, D.(1994)。Potential impact of valproic acid therapy on clozapine disposition。Biol Psychiatry，36，487-488。 | | 20. | Longo, L. P.、Salzman, C.(1995)。Valproic acid effects on serum concentrations of clozapine and norclozapine。Am J Psychiatry，152，650。 | | 21. | Centorrino, F.、Baldessarini, R. J.、Kando, J.、Frankenburg, F. R.、Volpicelli, S. A.、Puopolo, P. R.(1994)。Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate。Am J Psychiatry，151，123-125。 | | 22. | Facciola, G.、Avenoso, A.、Scordo, M. G.、Madia, A. G.、Ventimiglia, A.、Perucca, E.(1999)。Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders。Ther Drug Monit，21，341-345。 | | 23. | Sandson, N. B.、Cozza, K. L.、Armstrong, S. C.、Eckermann, G.、Fischer, B. A.、Phillips, B.(2007)。Clozapine case series。Psychosomatics，48，170-175。 | | 24. | Galappathie, N.、Seth, V.、Begum, A.(2014)。Clozapine re-trial in a patient with repeated life threatening pneumonias。Acta Biomed，85，175-179。 | | 25. | Haack, M. J.、Bak, M. L.、Beurskens, R.、Maes, M.、Stolk, L. M.、Delespaul, P. A.(2003)。Toxic rise of clozapine plasma concentrations in relation to inflammation。Eur Neuropsychopharmacol，13，381-385。 | | 26. | Schmidinger, S.、Hofer, A.(2014)。Pulmonary embolism and aspiration pneumonia after reexposure to clozapine: pulmonary adverse effects of clozapine。J Clin Psychopharmacol，34，385-387。 | | 27. | Eiermann, B.、Engel, G.、Johansson, I.、Zanger, U. M.、Bertilsson, L.(1997)。The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine。British Journal of Clinical Pharmacology，44，439-446。 | | 28. | Olessen, O. V.、Linnet, K.(2000)。Fluvoxamine-Clozapine Drug interaction: Inhibition in vitro of five Cytochrome P450 isoforms involved in Clozapine metabolism。Journal of Clinical Psychopharmacology，20，35-42。 | |